THE HABURAY FAMILY
Julia at 16 years?
|
12/10/1874-6/4/1958  |
This portrait was probably done on the occasion of Albert and Julia's wedding, ca. 1894. She is ca. 20 years and he is ca. 30. The photo on the right is perhaps fifty years later in 1944 on the occasion of their fiftieth wedding anniversary. One wonders whether the pearls are the same. 5/1/00: The following is a review of all the notes I have in my Haburay and Mathea files and floating around in my memory. Among the many research angles to be followed up are checking further with Peggy Timothy and others to see whether some of Julia Haburay's effects wound up with them. |
about 1944  |
 |
We know very little about the Haburays. Family tradition says that Julia Bernadette Haburay was born in Slovakia or Bohemia in 1874 and came to the US from Bohemia to work for a rich family as a governess. She may have been an orphan. We don't have a date for her arrival in the US. There is a small town in the far-northeastern corner of Slovakia named Habura (in the Laborec Valley in the Carpathian Mountains on Highway 559) which may possibly be where the Haburays came from. It is my belief, based on childhood memories, that she was from "Ruthenia." Both ideas may be correct.
Pantoprazole price irelandEtoricoxib beta 120 mg kaufen (Kaufen's) is the treatment of choice for chronic lymphocytic leukemia-like malignancies [21–24]. Other treatments include cyclosporine-based chemotherapy chemotherapy, which is an active immunotherapy for leukemia that uses interleukin (IL)-1, interleukin-2 (IL-2), and interleukin-4 (IL-4), rituximab (Rituxan); it is approved for people age 60 plus multiple myeloma, as well in people with chronic lymphocytic leukemia [25–27]. In adults, rituximab and cyclosporine chemotherapy are usually reserved for patients who have advanced disease or at least one significant symptom [28, 29]. These patients may require a more aggressive treatment to reduce the duration of relapse or to improve quality of life; in addition to chemotherapy and radiation therapy, immunotherapy is a standard treatment for lymphoproliferative diseases. Aging-associated immune disease Many conditions associated with the development of frailty, such as chronic obstructive pulmonary disease (COPD), have been linked to aging and immune dysfunction. In addition, the aging process itself may be responsible for a reduction in the frequency, activity, or severity of immune responses, resulting in an increased risk for illness. Chronic obstructive pulmonary disease (COPD) has been shown to be associated with increased risk for several chronic diseases, including heart failure, ischemic stroke, and type 2 diabetes, as well for mortality [8, 30⇓–32]. COPD is also associated with multiple immunosuppressive drugs, such as steroids and oral corticosteroids, increased risk for infection by pathogens such as bacteria and fungi [33]. Moreover, older individuals are thought to have more inflammatory microorganisms in the lungs, which leads to an increased risk of respiratory infections. Therefore, the elderly have increased risk for these infections as well [8]. Other chronic conditions linked to aging are chronic pulmonary diseases (such as bronchitis, emphysema, and COPD), osteoarthritis, peripheral arterial disease (such the carotid artery, which widens as we age), and renal failure. Tumor immunotherapy The combination of radiotherapy and chemotherapeutic age |